KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Inventory (2016 - 2025)

Historic Inventory for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $3.4 million.

  • LifeMD's Inventory rose 2974.7% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 2974.7%. This contributed to the annual value of $2.8 million for FY2024, which is 135.6% up from last year.
  • As of Q3 2025, LifeMD's Inventory stood at $3.4 million, which was up 2974.7% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Inventory ranged from a high of $3.8 million in Q3 2023 and a low of $1.2 million during Q1 2022
  • Over the past 5 years, LifeMD's median Inventory value was $2.8 million (recorded in 2024), while the average stood at $2.7 million.
  • As far as peak fluctuations go, LifeMD's Inventory surged by 20207.94% in 2021, and later crashed by 4427.93% in 2024.
  • Quarter analysis of 5 years shows LifeMD's Inventory stood at $1.6 million in 2021, then soared by 129.08% to $3.7 million in 2022, then decreased by 25.47% to $2.8 million in 2023, then increased by 1.36% to $2.8 million in 2024, then increased by 22.7% to $3.4 million in 2025.
  • Its Inventory stands at $3.4 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.0 million for Q1 2025.